Table 3. Hemodynamics and Bispectral Monitoring Variables in the 30 Patients in the Transitory Group
Data are mean ± SD. P values refer to between-period differences (analysis of variance).
*P < 0.05 versus baseline values.
†P < 0.05 versus recovery values.
Transitory group = patients who required transitory administration of myorelaxant for facilitation of invasive clinical procedures such as transesophageal echocardiography or bronchoscopy; baseline = study period (20 min) before administration of myorelaxant; myorelaxation = study period (20 min) after administration of myorelaxant; recovery = study period (20 min) after recovery of muscular activity; NS = not significant; Spo2= pulse oximetry; BIS = bispectral index; TOTPOW = total power of the signal; EMG = electromyographic activity; SQI = signal quality index.
